1. Home
  2. MIRA vs NUKK Comparison

MIRA vs NUKK Comparison

Compare MIRA & NUKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIRA
  • NUKK
  • Stock Information
  • Founded
  • MIRA 2020
  • NUKK 2013
  • Country
  • MIRA United States
  • NUKK United States
  • Employees
  • MIRA N/A
  • NUKK N/A
  • Industry
  • MIRA Biotechnology: Pharmaceutical Preparations
  • NUKK Blank Checks
  • Sector
  • MIRA Health Care
  • NUKK Finance
  • Exchange
  • MIRA Nasdaq
  • NUKK Nasdaq
  • Market Cap
  • MIRA 26.5M
  • NUKK 25.4M
  • IPO Year
  • MIRA 2023
  • NUKK N/A
  • Fundamental
  • Price
  • MIRA $1.29
  • NUKK $5.33
  • Analyst Decision
  • MIRA Strong Buy
  • NUKK
  • Analyst Count
  • MIRA 1
  • NUKK 0
  • Target Price
  • MIRA $17.00
  • NUKK N/A
  • AVG Volume (30 Days)
  • MIRA 804.3K
  • NUKK 11.5M
  • Earning Date
  • MIRA 11-11-2025
  • NUKK 11-14-2025
  • Dividend Yield
  • MIRA N/A
  • NUKK N/A
  • EPS Growth
  • MIRA N/A
  • NUKK N/A
  • EPS
  • MIRA N/A
  • NUKK N/A
  • Revenue
  • MIRA N/A
  • NUKK N/A
  • Revenue This Year
  • MIRA N/A
  • NUKK N/A
  • Revenue Next Year
  • MIRA N/A
  • NUKK N/A
  • P/E Ratio
  • MIRA N/A
  • NUKK N/A
  • Revenue Growth
  • MIRA N/A
  • NUKK N/A
  • 52 Week Low
  • MIRA $0.73
  • NUKK $1.30
  • 52 Week High
  • MIRA $2.56
  • NUKK $78.32
  • Technical
  • Relative Strength Index (RSI)
  • MIRA 40.50
  • NUKK 52.17
  • Support Level
  • MIRA $1.19
  • NUKK $4.25
  • Resistance Level
  • MIRA $1.72
  • NUKK $6.66
  • Average True Range (ATR)
  • MIRA 0.10
  • NUKK 0.79
  • MACD
  • MIRA -0.01
  • NUKK 0.23
  • Stochastic Oscillator
  • MIRA 18.25
  • NUKK 47.31

About MIRA MIRA Pharmaceuticals Inc.

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

About NUKK Nukkleus Inc.

Nukkleus Inc is a financial technology company that is focused on providing software and technology solutions. The company's operating segment includes General support services and Financial services. General support services include providing software, technology, customer sales and marketing, and risk management technology hardware and software solutions package under a GSA to a related party. Financial services include providing payment services from one fiat currency to another or to digital assets. It generates maximum revenue from the General support services segment. Geographically operates in USA, UK and Malta, with majority of revenue from United Kingdom (UK).

Share on Social Networks: